SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019306
Filing Date
2022-05-10
Accepted
2022-05-10 16:32:50
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q avro-10q_20220331.htm   iXBRL 10-Q 1893896
2 EX-10.1 avro-ex101_29.htm EX-10.1 51973
3 EX-31.1 avro-ex311_7.htm EX-31.1 17967
4 EX-31.2 avro-ex312_8.htm EX-31.2 18039
5 EX-32.1 avro-ex321_9.htm EX-32.1 11365
  Complete submission text file 0001564590-22-019306.txt   6195449

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA avro-20220331.xsd EX-101.SCH 46090
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avro-20220331_cal.xml EX-101.CAL 34413
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avro-20220331_def.xml EX-101.DEF 117211
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20220331_lab.xml EX-101.LAB 338755
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20220331_pre.xml EX-101.PRE 243082
60 EXTRACTED XBRL INSTANCE DOCUMENT avro-10q_20220331_htm.xml XML 938157
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 22910260
SIC: 2836 Biological Products, (No Diagnostic Substances)